["{\n\"step_by_step_thinking\": \"The provided documents describe the use of Eflornithine and Sulindac for various conditions. However, there is a specific document that mentions their effectiveness for prevention of progression in Familial Adenomatous Polyposis (FAP). The document 'Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis' discusses the use of Sulindac for treating intra-abdominal desmoid tumors in FAP patients. According to this document, Sulindac resulted in three complete and seven partial remissions, which suggests its effectiveness for preventing progression of desmoid tumors in FAP patients.\",\n\"answer_choice\": \"A\""]